FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/07/070305 [Registered on: 09/07/2024] Trial Registered Prospectively
Last Modified On: 09/03/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Ragi Granola compared to multivitamin in Peri - Menopausal Syndrome 
Scientific Title of Study   Effect of Ragi Granola in Peri - menopausal syndrome: A Randomized Controlled Pilot Study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Vidylaxmi N Aigali 
Designation  Post Graduate Scholar 
Affiliation  Dr D Y Patil College of ayurved and research centre  
Address  Third floor Departmrnt of Dravyaguns Vigyana Dr D Y Patil College of ayurved and research centre Pimpri Pune 18.
Third floor Departmrnt of Dravyaguns Vigyana Dr D Y Patil College of ayurved and research centre Pimpri Pune 18
Pune
MAHARASHTRA
411018
India 
Phone  8496873113  
Fax    
Email  vidyaaigali13@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Abhijeet Shirkande 
Designation  Assosciate Professor 
Affiliation  Dr D Y Patil College of ayurveda and research centre 
Address  Third floor Departmrnt of Dravyaguns Vigyana Dr D Y Patil College of ayurved and research centre Pimpri Pune 18
Third floor Departmrnt of Dravyaguns Vigyana Dr D Y Patil College of ayurved and research centre Pimpri Pune 18
Pune
MAHARASHTRA
411018
India 
Phone  9975253664  
Fax    
Email  abhijeet.shirkande@dpu.edu.in  
 
Details of Contact Person
Public Query
 
Name  Dr Abhijeet Shirkande 
Designation  Assosciate Professor 
Affiliation  Dr D Y Patil College of ayurveda and research centre 
Address  Third floor Departmrnt of Dravyaguns Vigyana Dr D Y Patil College of ayurved and research centre Pimpri Pune 18
Third floor Departmrnt of Dravyaguns Vigyana Dr D Y Patil College of ayurved and research centre Pimpri Pune 18
Pune
MAHARASHTRA
411018
India 
Phone  9975253664  
Fax    
Email  abhijeet.shirkande@dpu.edu.in  
 
Source of Monetary or Material Support  
Dr D Y Patil College of ayurved and research centre pimpri, Pune pin code-411018 maharashtra,INDIA 
 
Primary Sponsor  
Name  Self 
Address  Dr D Y Patil College of ayurved and research centre Pimpri Pune 411018 maharashtra INDIA 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Vidyalaxmi NAigali  Dr.D.Y.Patil college of ayurved and research centre,pimpri,pune  dept of kayachikitsa and swastavrutta,striroga evum prasuti opd-5,6,15,7Dr.D.Y.Patil college of ayurved and research centre,pimpri,pune
Pune
MAHARASHTRA 
8496873113

vidyaaigali13@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
DR DYPCA RC INTITUTIONAL ETHICS COMMITEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N958||Other specified menopausal and perimenopausal disorders. Ayurveda Condition: ARTAVADOSHAH/ARTAVADUSHTIH/RAJODOSHAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugOther than Classical(1) Medicine Name: Ragi granola , Reference: NA, Route: Oral, Dosage Form: Churna/ Powder, Dose: 30(g), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: -), Additional Information: -
2Comparator ArmDrugOther than Classical(1) Medicine Name: Multivitamin , Reference: NA, Route: Oral, Dosage Form: Capsules, Dose: 30(mg), Frequency: od, Bhaishajya Kal: Antarabhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: -), Additional Information: -
 
Inclusion Criteria  
Age From  40.00 Year(s)
Age To  55.00 Year(s)
Gender  Female 
Details  AGE- More than 40 years and less than 55 years
Score of 10 or more as per the CCRAS scoring of menopausal syndrome 
 
ExclusionCriteria 
Details  AGE - LESS THAN 40 YEARS AND MORE THAN 55 YEARS
CCRAS menopausal score less than 10
the permanent cessation of periods from past 12 months
cases undergoing treatment for any other serious illness 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
to assess the efficacy of ragi granola in management of perimenopausal syndrome  screening will be done on 20 patients 
 
Secondary Outcome  
Outcome  TimePoints 
To assess the efficacy of ragi granola in perimenopausal syndrome   screening will be done on 0 & 15th day
follow ups will be on 15th & 30th days
total duration of the study will be of 30 days 
 
Target Sample Size   Total Sample Size="20"
Sample Size from India="20" 
Final Enrollment numbers achieved (Total)= "20"
Final Enrollment numbers achieved (India)="20" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   21/07/2024 
Date of Study Completion (India) 15/02/2025 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) 15/02/2025 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Completed 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The perimenopause is an ill-defined time period that surrounds the final years of a women’s reproductive life.the peri-menopausal syndrome associated with profound reproductive and hormonal changes 
 

It is a randomised controlled pilot study in which treatment(ragi granola) will be carried out on 20 patients of perimenopausal syndrome screening will be done on 0 and 15th day
follow ups will be on 15th and 30th days total duration of the study will be of 30 days the age group is taken more than 40 years and less than 55 years


 
Close